Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
305.7 USD | -0.55% | +1.56% | +6.13% |
06-06 | Transcript : Amgen Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-06-2024 09:00 AM | |
06-05 | Amgen Says Phase 3 Trial of Potential Autoimmune Disease Treatment Meets Endpoints | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.13% | 165B | |
+43.64% | 749B | |
+39.42% | 605B | |
-6.58% | 351B | |
+19.72% | 328B | |
+8.78% | 292B | |
+11.92% | 216B | |
-2.62% | 214B | |
+0.03% | 167B | |
+1.39% | 123B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating